<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>938</id><JournalTitle>DYNAMIC BIODYNAMER NANO-SYSTEMS IN BIOPHARMACEUTICAL DELIVERY: DESIGN, CHARACTERIZATION, AND THERAPEUTIC APPLICATIONS</JournalTitle><Abstract>Dynamic biodynamer nano-systems have emerged as a novel and highly adaptable platform for the delivery of peptide and
protein therapeutics, addressing critical limitations associated with conventional drug delivery approaches. Peptides and
proteins, despite their high specificity and therapeutic potential, are often hindered by poor stability, enzymatic
degradation, low bioavailability, and limited permeability across biological barriers. Biodynamers, characterized by
dynamic covalent bonding and reversible self-assembly, offer unique advantages in forming nano-complexes and nanoemulsions capable of encapsulating and protecting these sensitive biomolecules. This review provides a comprehensive
overview of the design, formation mechanisms, and physicochemical characterization of biodynamer-based nano-systems,
highlighting their role in enhancing drug stability and enabling controlled and stimuli-responsive release. The incorporation
of targeting ligands and surface modifications further improves site-specific delivery, cellular uptake, and therapeutic
efficiency while minimizing systemic toxicity. In addition, these nano-formulations demonstrate favorable
pharmacokinetic and pharmacodynamic profiles, including prolonged circulation time and sustained drug release. The
review also discusses critical aspects of biocompatibility, toxicity, and safety, along with the challenges associated with
large-scale manufacturing, regulatory approval, and reproducibility. Furthermore, the wide-ranging applications of
biodynamer nano-systems in chronic diseases such as cancer, diabetes, and neurodegenerative disorders, as well as their
potential in advanced biopharmaceutical fields like gene delivery and vaccine development, are explored. Despite existing
challenges, ongoing advancements in material design and nanotechnology are expected to facilitate the translation of these
systems into clinical practice. Overall, biodynamer-based nano-systems represent a promising and innovative approach for
improving the delivery and therapeutic performance of peptide and protein drugs.</Abstract><Email>rselvapharmacy@gmail.com</Email><articletype>Research</articletype><volume>17</volume><issue>2</issue><year>2026</year><keyword>Biodynamers; Nano-drug delivery; Peptide and protein therapeutics; Targeted nano-systems</keyword><AUTHORS>Dr. Ravichandran S, Dr. Bhavani J, Baskar R, Jaspher Stalin S, Suresh Kumar S</AUTHORS><afflication>Principal cum HOD, Department of Pharmacognosy, St.Mary's Institute of Pharmacy, Chinthamani, Puliangudi. -627855,
Tamil Nadu, India.
Vice Pricipal cum HOD, Department of Pharmaceutics, St.Mary's Institute of Pharmacy, Chinthamani, Puliangudi. -
627855</afflication></Article></Articles>